Huiping Tu

Dr. Tu has been working with USP for over 10 years. Currently she is the Senior Principal Scientist to manage the Microbiology Expert Committee and leads the effort to develop the microbiology related USP general chapters and standards. Her previous role in USP was the Director of the Biologics Laboratory, and she managed the bioanalytical, bioassay and microbiology teams. She oversaw daily operation of the laboratory and interactions with other USP departments, the global biological units and stakeholders to promote good quality of biotherapeutic products globally.

Prior to joining USP in 2012, she worked most recently at Merck, where she was a Senior Research Scientist at Cardiovascular Diseases Franchise to work in early drug discovery process ranging from target identification/validation, lead compound identification /optimization and safety assessment.

Dr. Huiping Tu received her M.S. in Organic Chemistry and Ph. D. in Physiology. Dr. Tu has a broad scientific background in the fields of cardiovascular and neurological diseases with deep and broad expertise in microbiology, molecular/cell biology, biochemistry, and analytical chemistry. She has more than 20 years’ experience in pharmaceutical industry, academia, and regulatory science with in-depth knowledge of USP-NF and the development of reference standards relevant to pharmaceutical products. Dr. Tu is the leading author or co-author of many prestigious peer-reviewed publications including Cell; J. Clinical Investigation and Neuron and holds several patents.